
Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market Report 2026
Global Outlook – By Product Type (Respiratory Panels, Gastrointestinal Panels, Vector-Borne Disease Panels, Other Product Types), By Animal Type (Companion Animals, Livestock, Other Animal Types), By Component (Test Kits, Reagents And Master Mixes, Sample Collection Swabs And Tubes, Laboratory Consumables, Instruments And Equipment), By End User (Veterinary Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035
Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market Overview
• Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels market size has reached to $1.22 billion in 2025 • Expected to grow to $1.77 billion in 2030 at a compound annual growth rate (CAGR) of 7.8% • Growth Driver: Rising Prevalence Of Animal Infectious Diseases Is Fueling The Growth Of The Market Due To Increasing Pathogen Transmission From Higher Animal Population Density • Market Trend: Advanced Molecular Testing Supports Responsible Antibiotic Use In Equine Healthcare • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market?
Veterinary rapid syndromic polymerase chain reaction (PCR) panels are advanced diagnostic tools that utilize PCR technology to simultaneously identify multiple pathogens from a single animal sample, guided by observed clinical symptoms or syndromes. They allow for quick and precise detection of infectious diseases, enabling timely and targeted treatment, minimizing unnecessary antibiotic use, and enhancing overall disease management and outbreak control in veterinary care. The main product types of veterinary rapid syndromic polymerase chain reaction (PCR) panels include respiratory panels, gastrointestinal panels, vector-borne disease panels, and other product types. Respiratory panels refer to multiplex molecular diagnostic tools used to simultaneously detect multiple pathogens in veterinary samples for rapid disease identification and outbreak control. The testing framework includes animal types such as companion animals, livestock, and other animal types. The various components involved are test kits, reagents and master mixes, sample collection swabs and tubes, laboratory consumables, and instruments and equipment, and they are used by several end users such as veterinary hospitals and clinics, diagnostic laboratories, research institutes, and other end users.
What Is The Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market Size and Share 2026?
The veterinary rapid syndromic polymerase chain reaction (PCR) panels market size has grown strongly in recent years.It will grow from $1.22 billion in 2025 to $1.31 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to zoonotic disease outbreaks driving diagnostic demand, growth in intensive livestock farming systems, increasing companion animal healthcare expenditure, limitations of conventional culture-based diagnostic methods, rising awareness of antimicrobial resistance concerns.What Is The Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market Growth Forecast?
The veterinary rapid syndromic polymerase chain reaction (PCR) panels market size is expected to see strong growth in the next few years.It will grow to $1.77 billion by 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to expansion of AI-assisted diagnostic interpretation tools, increasing adoption of precision veterinary medicine approaches, regulatory enforcement of antimicrobial stewardship programs, rising demand for decentralized rapid testing solutions, integration of high-throughput multiplex molecular diagnostics in veterinary workflows.Major trends in the forecast period include expansion of point-of-care rapid molecular diagnostic testing in veterinary clinics, growing adoption of syndromic pathogen detection for early disease differentiation in animals, increasing demand for multiplex PCR assays to reduce diagnostic turnaround time, rising emphasis on antibiotic stewardship-driven diagnostic decision making, expansion of centralized veterinary reference laboratory testing networks.Global Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market Segmentation
1) By Product Type: Respiratory Panels, Gastrointestinal Panels, Vector-Borne Disease Panels, Other Product Types 2) By Animal Type: Companion Animals, Livestock, Other Animal Types 3) By Component: Test Kits, Reagents And Master Mixes, Sample Collection Swabs And Tubes, Laboratory Consumables, Instruments And Equipment 4) By End User: Veterinary Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users Subsegments: 1) By Respiratory Panels: Canine Respiratory Pathogen Panel, Feline Respiratory Pathogen Panel, Equine Respiratory Pathogen Panel, Avian Respiratory Pathogen Panel, Multi Species Respiratory Pathogen Panel 2) By Gastrointestinal Panels: Canine Gastrointestinal Pathogen Panel, Feline Gastrointestinal Pathogen Panel, Bovine Gastrointestinal Pathogen Panel, Swine Gastrointestinal Pathogen Panel, Multi Species Gastrointestinal Pathogen Panel 3) By Vector-Borne Disease Panels: Tick Borne Disease Panel, Flea Borne Disease Panel, Mosquito Borne Disease Panel, Canine Vector Borne Disease Panel, Multi Species Vector Borne Disease Panel 4) By Other Product Types: Neurological Disease Panel, Dermatological Infection Panel, Reproductive Disease Panel, Urinary Tract Infection Panel, Zoonotic Disease PanelWhat Are The Drivers Of The Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market?
The growing prevalence of infectious diseases in animals is expected to propel the growth of the veterinary rapid syndromic polymerase chain reaction (PCR) panels industry going forward.Infectious diseases in animals are illnesses caused by pathogenic microorganisms that invade animal hosts and can spread directly or indirectly between animals or from animals to humans.The rise in the prevalence of infectious diseases in animals is driven by increased animal population density, as closer contact between animals facilitates faster transmission and spread of pathogens.Veterinary rapid syndromic polymerase chain reaction (PCR) panels help detect infectious diseases in animals by enabling rapid and accurate detection of multiple pathogens simultaneously, supporting early diagnosis, timely treatment, and effective disease control.For instance, in November 2023, according to the Colorado Department of Agriculture, a US-based state government agency responsible for overseeing animal health and agricultural regulations, double the number of canine infectious respiratory disease cases were reported compared to the levels typically observed during a standard outbreak period, with similar surges simultaneously documented across at least 10 U.S.states between 2022 and 2023.Therefore, the growing prevalence of infectious diseases in animals is driving the growth of the Veterinary Rapid Syndromic PCR Panels market. The growing companion animal ownership is expected to propel the growth of the veterinary rapid syndromic polymerase chain reaction (PCR) panels industry going forward.Companion animal ownership refers to the practice of individuals or households keeping domesticated animals such as dogs and cats as pets, forming bonds that include providing healthcare and veterinary services.The rising trend of companion animal ownership is largely driven by shifting societal attitudes, as pets are increasingly regarded as family members, encouraging more households to adopt animals and invest in their overall well-being, including health monitoring and disease management.Veterinary rapid syndromic PCR panels allow fast, accurate multi-pathogen detection in companion animals, enabling early diagnosis, targeted treatment, and improved overall pet care.For instance, in December 2024, according to the American Veterinary Medical Association (AVMA), a US-based nonprofit organization that serves as the leading authority on veterinary medicine and animal health, the total population of pet dogs in the United States reached 89.7 million in 2024, rebounding from 80.1 million in 2023, reflecting a rise of approximately 9.6 million dogs within a single year.Therefore, growing companion animal ownership is driving the growth of the veterinary rapid syndromic polymerase chain reaction (PCR) panels industry.Key Players In The Global Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market
Major companies operating in the veterinary rapid syndromic polymerase chain reaction (pcr) panels market are Thermo Fisher Scientific Inc., Zoetis Inc., bioMérieux SA, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N. V., Neogen Corporation, Seegene Inc., Bioneer Corporation, Molbio Diagnostics Private Limited, Sansure Biotech Inc., INDICAL BIOSCIENCE GmbH, Royal GD, GeneReach Biotechnology Corp., Ring Biotechnology Co. Ltd., Biomeme Inc., BioNote Inc., Agrolabo S. p. A., Genekam Biotechnology AG, MEGACOR Diagnostik GmbHGlobal Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market Trends and Insights
Major companies operating in the veterinary rapid syndromic polymerase chain reaction (PCR) panels market are focusing on developing rapid, multiplex PCR-based veterinary diagnostics to improve overall animal health outcomes. Rapid, multiplex PCR-based veterinary diagnostics are molecular testing techniques that quickly identify multiple pathogens in animal samples at once, enabling accurate diagnosis and timely treatment decisions. For instance, in June 2025, bioMérieux, a France-based in vitro diagnostics company, introduced the VETFIRE PCR kit for equine infectious respiratory disease testing. The launch leverages the BIOFIRE SPOTFIRE System to provide rapid, point-of-care detection of seven respiratory pathogens in horses, delivering highly accurate results in less than 20 minutes. It uses a simple nasopharyngeal swab that supports informed veterinary decisions for treatment, isolation, and management of suspected infections. The integration of advanced PCR technology with the SPOTFIRE platform enables faster outbreak control, improves equine health management, and offers a scalable, user-friendly solution for routine and competition-related health screenings across the United Kingdom, Ireland, and France.Regional Insights
North America was the largest region in the veterinary rapid syndromic polymerase chain reaction (PCR) panels market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market?
The veterinary rapid syndromic polymerase chain reaction (PCR) panels market consists of sales of nucleic acid extraction kits, positive and negative control panels, multiplex assay panels, and data analysis tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.What is the Market Assessment and Strategic Outlook for the Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Industry?
The veterinary rapid syndromic polymerase chain reaction (pcr) panels market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary rapid syndromic polymerase chain reaction (pcr) panels industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.What is the Market Assessment and Strategic Outlook for the Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market Report 2026?
The veterinary rapid syndromic polymerase chain reaction (PCR) panels market research report is one of a series of new reports from The Business Research Company that provides veterinary rapid syndromic polymerase chain reaction (PCR) panels market statistics, including veterinary rapid syndromic polymerase chain reaction (PCR) panels industry global market size, regional shares, competitors with a veterinary rapid syndromic polymerase chain reaction (PCR) panels market share, detailed veterinary rapid syndromic polymerase chain reaction (PCR) panels market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary rapid syndromic polymerase chain reaction (PCR) panels industry. This veterinary rapid syndromic polymerase chain reaction (PCR) panels market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.31 billion |
| Revenue Forecast In 2035 | $1.77 billion |
| Growth Rate | CAGR of 7.8% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Animal Type, Component, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Thermo Fisher Scientific Inc., Zoetis Inc., bioMérieux SA, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N. V., Neogen Corporation, Seegene Inc., Bioneer Corporation, Molbio Diagnostics Private Limited, Sansure Biotech Inc., INDICAL BIOSCIENCE GmbH, Royal GD, GeneReach Biotechnology Corp., Ring Biotechnology Co. Ltd., Biomeme Inc., BioNote Inc., Agrolabo S. p. A., Genekam Biotechnology AG, MEGACOR Diagnostik GmbH |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
